Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor.

Tapia F, Vogel T, Genzel Y, Behrendt I, Hirschel M, Gangemi JD, Reichl U.

Vaccine. 2014 Feb 12;32(8):1003-11. doi: 10.1016/j.vaccine.2013.11.044. Epub 2013 Nov 19.

PMID:
24269322
2.

Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophages.

Murphy EA, Davis JM, McClellan JL, Carmichael MD, Rooijen NV, Gangemi JD.

J Interferon Cytokine Res. 2011 Jun;31(6):501-8. doi: 10.1089/jir.2010.0143. Epub 2011 Feb 25.

PMID:
21352081
3.

Exercise stress increases susceptibility to influenza infection.

Murphy EA, Davis JM, Carmichael MD, Gangemi JD, Ghaffar A, Mayer EP.

Brain Behav Immun. 2008 Nov;22(8):1152-5. doi: 10.1016/j.bbi.2008.06.004. Epub 2008 Jun 21.

PMID:
18616997
4.

Quercetin reduces susceptibility to influenza infection following stressful exercise.

Davis JM, Murphy EA, McClellan JL, Carmichael MD, Gangemi JD.

Am J Physiol Regul Integr Comp Physiol. 2008 Aug;295(2):R505-9. doi: 10.1152/ajpregu.90319.2008. Epub 2008 Jun 25.

5.

Bioactivities of gossypol, 6-methoxygossypol, and 6,6'-dimethoxygossypol.

Wang X, Beckham TH, Morris JC, Chen F, Gangemi JD.

J Agric Food Chem. 2008 Jun 25;56(12):4393-8. doi: 10.1021/jf073297u. Epub 2008 Jun 3.

PMID:
18517219
6.

Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage.

Davis JM, Murphy EA, Carmichael MD, Zielinski MR, Groschwitz CM, Brown AS, Gangemi JD, Ghaffar A, Mayer EP.

Am J Physiol Regul Integr Comp Physiol. 2007 Jun;292(6):R2168-73. Epub 2007 Mar 1.

7.

Antiinflammatory properties of the muscadine grape (Vitis rotundifolia).

Greenspan P, Bauer JD, Pollock SH, Gangemi JD, Mayer EP, Ghaffar A, Hargrove JL, Hartle DK.

J Agric Food Chem. 2005 Nov 2;53(22):8481-4.

PMID:
16248541
8.

An evaluation of Echinacea angustifolia in experimental rhinovirus infections.

Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD.

N Engl J Med. 2005 Jul 28;353(4):341-8.

9.

Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans.

Woelkart K, Koidl C, Grisold A, Gangemi JD, Turner RB, Marth E, Bauer R.

J Clin Pharmacol. 2005 Jun;45(6):683-9.

PMID:
15901750
10.

Effect of interferon alpha and cell cycle progression on translation mediated by the hepatitis C virus 5' untranslated region: a study using a transgenic mouse model.

Takeda Y, Okoshi S, Suzuki K, Yano M, Gangemi JD, Jay G, Asakura H, Aoyagi Y.

J Viral Hepat. 2004 Jan;11(1):33-44.

PMID:
14738556
11.

Alpha interferon augments cidofovir's antiviral and antiproliferative activities.

Johnson JA, Gangemi JD.

Antimicrob Agents Chemother. 2003 Jun;47(6):2022-6.

12.

Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.

Korba BE, Cote P, Hornbuckle W, Schinazi R, Gangemi JD, Tennant BC, Gerin JL.

Antivir Ther. 2000 Jun;5(2):95-104.

PMID:
10971862
13.

The medicinal potential of blueberries. A new nutraceutical for South Carolina farmers.

Bradham RR, Gangemi JD.

J S C Med Assoc. 2000 Jul;96(7):300-3. No abstract available.

PMID:
10933008
14.

Ineffectiveness of echinacea for prevention of experimental rhinovirus colds.

Turner RB, Riker DK, Gangemi JD.

Antimicrob Agents Chemother. 2000 Jun;44(6):1708-9.

15.

Quantitative immunodetection of viral oncoprotein levels in human papillomavirus-transformed human cells.

Johnson JA, Gangemi JD.

Methods Mol Med. 2000;24:361-4. doi: 10.1385/1-59259-245-7:361.

PMID:
21331922
16.

Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis.

Wintergerst U, Gangemi JD, Whitley RJ, Chatterjee S, Kern ER.

Antiviral Res. 1999 Nov;44(1):75-8.

PMID:
10588335
17.

IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression.

Johnson JA, Hochkeppel HK, Gangemi JD.

J Interferon Cytokine Res. 1999 Oct;19(10):1107-16.

PMID:
10547150
18.
19.

Mycoplasma penetrans and other mycoplasmas in urine of human immunodeficiency virus-positive children.

Hussain AI, Robson WL, Kelley R, Reid T, Gangemi JD.

J Clin Microbiol. 1999 May;37(5):1518-23.

20.

Experimentally induced infection with Helicobacter pylori in squirrel monkeys (Saimiri spp.): clinical, microbiological, and histopathologic findings.

Stadtländer CT, Gangemi JD, Stutzenberger FJ, Lawson JW, Lawson BR, Khanolkar SS, Elliott-Raynor KE, Farris HE Jr, Fulton LK, Hill JE, Huntington FK, Lee CK, Monath TP.

Lab Anim Sci. 1998 Jun;48(3):303-9. No abstract available.

PMID:
10090035
21.

Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate.

Stadtländer CT, Gangemi JD, Khanolkar SS, Kitsos CM, Farris HE Jr, Fulton LK, Hill JE, Huntington FK, Lee CK, Monath TP.

Dig Dis Sci. 1996 Sep;41(9):1853-62.

PMID:
8794806
22.

Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells.

Wintergerst U, Gangemi JD, Kern ER, Whitley RJ, Chatterjee S.

Antiviral Res. 1996 Aug;32(1):27-34.

PMID:
8863993
23.

Functional inactivation but not structural mutation of p53 causes liver cancer.

Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G.

Nat Genet. 1995 Jan;9(1):41-7.

PMID:
7704023
24.

HPV replication in experimental models: effects of interferon.

Gangemi JD, Pirisi L, Angell M, Kreider JW.

Antiviral Res. 1994 Jul;24(2-3):175-90. Review.

PMID:
7526790
25.
26.
27.

Poly I:C-induced antiviral and cytotoxic activities are mediated by different mechanisms.

Pyo S, Gangemi JD, Ghaffar A, Mayer EP.

Int J Immunopharmacol. 1993 May;15(4):477-86.

PMID:
8396072
28.

Cross-species antiviral activity of a recombinant human alpha-interferon hybrid.

Ghaffar A, Mayer EP, Barnhart DC, Pyo S, Szymaniec S, Hochkeppel HK, Gangemi JD.

Ann N Y Acad Sci. 1992 Jun 16;653:314-22. Review. No abstract available.

PMID:
1320843
29.
30.

Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS.

De Castro LM, Kern ER, De Clercq E, Ghaffar A, Mayer EP, Vogt PE, Gangemi JD.

Antiviral Res. 1991 Jul;16(1):101-14.

PMID:
1663726
31.

Use of human monocytes in the evaluation of antiviral drugs: quantitation of HSV-1 cytopathic effects.

Lazdins J, Alteri E, Cook KW, Burgin C, Gangemi JD.

Antiviral Res. 1990 Apr;13(4):175-86.

PMID:
2166467
32.

Drug targeting: anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine.

Midoux P, Negre E, Roche AC, Mayer R, Monsigny M, Balzarini J, De Clercq E, Mayer E, Ghaffar A, Gangemi JD.

Biochem Biophys Res Commun. 1990 Mar 30;167(3):1044-9.

PMID:
2157421
33.

9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.

Gangemi JD, Cozens RM, De Clercq E, Balzarini J, Hochkeppel HK.

Antimicrob Agents Chemother. 1989 Nov;33(11):1864-8.

34.
35.

Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid.

Gangemi JD, Lazdins J, Dietrich FM, Matter A, Poncioni B, Hochkeppel HK.

J Interferon Res. 1989 Apr;9(2):227-37.

PMID:
2541210
36.

An ultrastructural examination of murine alveolar macrophages following intranasal administration of propionibacterium acnes.

Hightower JA, Welsh MG, Jackson RA, Gangemi JD.

Histol Histopathol. 1987 Jul;2(3):217-22.

PMID:
2980723
37.
38.

Role of pulmonary macrophages in resistance to experimental metastasis.

Jackson RA, Lill PH, Gangemi JD.

J Leukoc Biol. 1986 Nov;40(5):575-87.

PMID:
3464675
39.
40.

Bronchoalveolar lavage and the immunology of primary lung cancer.

Olsen GN, Gangemi JD.

Chest. 1985 May;87(5):677-83. Review.

PMID:
3886317
41.

Phagocytic activity of alveolar macrophages in patients with bronchogenic carcinoma.

Gangemi JD, Olsen GN, Fechter C, Hightower JA, Bauguess CT, Krech L.

Cancer Immunol Immunother. 1985;20(2):158-66.

PMID:
3849978
42.

Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery.

Bryan CS, Morgan SL, Jordan AB, Smith CW, Sutton JP, Gangemi JD.

Antimicrob Agents Chemother. 1984 Jan;25(1):37-9.

43.

Comparison of cefamandole and cefazolin during cardiopulmonary bypass.

Bryan CS, Smith CW Jr, Sutton JP, Allen WB, Blanding R, Gangemi JD.

J Thorac Cardiovasc Surg. 1983 Aug;86(2):222-5.

PMID:
6348425
44.

Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and -nonresponsive mice by Propionibacterium acnes.

Gangemi JD, Hightower JA, Jackson RA, Maher MH, Welsh MG, Sigel MM.

Infect Immun. 1983 Feb;39(2):726-35.

45.

Opsonization of alphaviruses in hamsters.

Jahrling PB, Hesse RA, Anderson AO, Gangemi JD.

J Med Virol. 1983;12(1):1-16.

PMID:
6311964
46.

Polypeptide synthesis catalysed by components of Pichinde virus disrupted by detergent.

Chinault DN, Thompson HA, Gangemi JD.

J Gen Virol. 1981 Jul;55(Pt 1):213-7.

PMID:
7299369
47.

Natural killer cell activation in lipopolysaccharide-responsive and -non responsive mice by viral and bacterial agents.

Gangemi JD, Ghaffar A, Trauger RL, Sigel MM.

J Reticuloendothel Soc. 1980 May;27(5):525-33. No abstract available.

PMID:
6989996
48.

Structural polypeptides of Machupo virus.

Gangemi JD, Rosato RR, Connell EV, Johnson EM, Eddy GA.

J Gen Virol. 1978 Oct;41(1):183-8.

PMID:
212518
49.

Particle heterogeneity in vaccinia virus populations during passage.

Gangemi JD, Sharp DG.

Virology. 1978 Mar;85(1):262-70. No abstract available.

PMID:
644883
50.

Production of Venezuelan equine encephalitis virus in cells grown on artificial capillaries.

Johnson AD, Eddy GA, Gangemi JD, Ramsburg HH, Metzger JF.

Appl Environ Microbiol. 1978 Feb;35(2):431-4.

Supplemental Content

Loading ...
Support Center